HY

Hyundai ADM Bio lnc.

Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.

187660 | KO

Overview

Corporate Details

ISIN(s):
KR7187660006
LEI:
Country:
South Korea
Address:
서울특별시 종로구 새문안로5길 19, 7층 711호(당주동, 로얄빌딩), 종로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hyundai ADM Bio Inc. is a leading Korean Contract Research Organization (CRO) providing comprehensive clinical trial services to pharmaceutical companies and bio ventures. The company offers end-to-end support across all study phases, specializing in clinical operations and medical writing to ensure high-quality, globally standardized trial execution. Leveraging extensive experience and a track record of successful clinical trials, Hyundai ADM Bio positions itself as a key partner in drug development. In addition to its CRO services, the company engages in its own research and development, notably advancing the anti-cancer drug candidate 'Penitrium' in collaboration with its parent company, Hyundai Bioscience.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-09-01 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.8 KB
2025-08-20 00:00
Share Issue/Capital Change
주요사항보고서(제3자의전환사채매수선택권행사)
Korean 41.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 93.6 KB
2025-08-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-07-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 13.4 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.4 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 16.4 KB
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 18.6 KB
2025-07-31 00:00
Board/Management Information
대표이사변경
Korean 15.3 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 68.0 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 20.9 KB
2025-07-14 00:00
Share Issue/Capital Change
전환청구권행사
Korean 9.0 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Hyundai ADM Bio lnc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hyundai ADM Bio lnc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hyundai ADM Bio lnc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea
251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America
ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan
8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland
APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea
149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America
ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy
ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America
ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan
246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.